Related Experiment Video
Updated: Nov 28, 2025

Electrochemiluminescence Assays for Human Islet Autoantibodies
Published on: March 23, 2018
Cardiovascular disease in patients with type 1 diabetes: Early evaluation, risk factors and possible relation with
Mei Shi1, Rong Tang1, Fansu Huang1
1Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, Changsha, Hunan, China.
Insights
Cardiovascular disease is the leading cause of death in type 1 diabetes (T1D). Early assessment and management of cardiovascular risk factors are crucial for improving outcomes in T1D patients.
Area of Science:
- Endocrinology
- Cardiology
- Diabetology
Background:
- Cardiovascular disease (CVD) is the primary cause of mortality in type 1 diabetes (T1D), with risks 2-10 times higher than the general population.
- Pathological processes for CVD in T1D initiate in childhood, despite clinical manifestations appearing later in life.
- Established risk factors like hypertension, dyslipidemia, and diabetic nephropathy significantly impact CVD development in T1D.
Purpose of the Study:
- To provide a comprehensive review of cardiovascular risk in type 1 diabetes.
- To explore the epidemiology, early assessment methods, and risk factors associated with CVD in T1D.
- To investigate the potential role of cardiac autoimmunity and the impact of intensive insulin therapy on cardiovascular risk.
Main Methods:
- Literature review focusing on cardiovascular disease in type 1 diabetes.
- Analysis of epidemiological data and established cardiovascular risk factors.
- Exploration of emerging research on cardiac autoimmunity and intensive insulin therapy effects.
Main Results:
- Subclinical CVD can be detected in adolescence using methods like carotid intima-media thickness and pulse wave velocity.
- Annual systematic assessment and management of cardiovascular risk factors are recommended by clinical guidelines.
- Further research is needed to understand the influence of intensive insulin therapy and cardiac autoimmunity mechanisms on CVD in T1D.
Conclusions:
- Early detection and management of cardiovascular risk factors are essential for mitigating CVD mortality in type 1 diabetes.
- Understanding the interplay between cardiac autoimmunity, intensive insulin therapy, and CVD progression is critical for developing novel therapeutic strategies.
- A multi-faceted approach addressing traditional risk factors and novel mechanisms is necessary to reduce the cardiovascular burden in T1D.
Abstract:
Cardiovascular disease now is the leading cause of mortality among patients with type 1 diabetes (T1D). The risk of death from cardiovascular events in subjects with T1D is 2-10 times higher than the general population, depending on blood glucose control. Although complications of cardiovascular disease occur in middle and old age, pathological processes begin in childhood. Some methods used to evaluate subclinical cardiovascular disease, such as carotid intima-media thickness and pulse wave velocity, can detect early cardiovascular abnormalities in adolescence. The effect of risk factors including hypertension, dyslipidemia and diabetic nephropathy on cardiovascular disease has been well studied. According to the current clinical practice recommendations from the American Diabetes Association, cardiovascular risk factors should be systematically assessed at least annually and treated as recommended. And yet, the effects of intensive insulin therapy on cardiovascular risk, as well as the mechanisms of cardiac autoimmunity require further studying. This review concentrates on the cardiovascular risk in type 1 diabetes in order to provide a comprehensive outlook of its epidemiology, early assessment, risk factors and possible relations with cardiac autoimmunity, aiming to propose promising therapeutic strategies.
More Related Videos
Related Concept Videos
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Coronary Artery Disease I: Introduction
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Psychoneuroimmunology: Diabetes and Cancer

